Significance of Lgr5+ve cancer stem cells in the colon and rectum

Hidekazu Takahashi, Hideshi Ishii, Naohiro Nishida, Ichiro Takemasa, Tsunekazu Mizushima, Masataka Ikeda, Takehiko Yokobori, Koshi Mimori, Hirofumi Yamamoto, Mitsugu Sekimoto, Yuichiro Doki, Masaki Mori

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

Purpose: Although recent studies show that leucine-rich repeat-containing G-protein-coupled receptor 5 (Lgr5)+ve cells targeted by Wnt drive self-renewal in the skin and gastrointestinal organs, the clinicopathological significance of Lgr5+ve cancer stem cells (CSCs) of the colon remains to be elucidated. Experimental Design. We studied the Wnt-targeted Lgr5 pathway in colorectal cancer (CRC). The expression of LGR5, c-MYC, p21CIP1/WAF1/CDKN1A, glutaminase (GLS), and miRs-23a and -23b (that target LGR5 and GLS) was evaluated by quantitative real-time reverse-transcription polymerase chain reaction (RT-PCR). The Lgr5 protein was evaluated by immunohistochemistry. The clinical relevance of gene expression in terms of patient survival was also evaluated. Results: Overexpression of LGR5 was significantly associated with expression of c-MYC, p21CIP1/WAF1/ CDKN1A, and GLS (p<0.0001), and inversely associated with miR-23a/b (p<0.05). Immunohistochemical analysis indicated that Lgr5 may be embedded in benign adenomas, localized at the tumor-host interface, and detectable over a broad area in established tumors. High level of LGR5 expression was associated with poor prognosis for CRC cancer patients (disease-free survival; p<0.05). Conclusions: This study supports a significant role for LGR5 in the CSC hypothesis in CRC: (1) Lgr5+ve CSCs, presumably derived from normal stem cells in colonic crypts, proliferate, and the gene is overexpressed during CRC development; (2) LGR5 expression is associated with activation of Wnt pathway, including oncogenic c-MYC and high energy production via glutaminolysis; (3) LGR5 expression may be a poor prognostic factor for CRC patients. Further study of LGR5 should contribute to the development of CSC-based cancer therapeutics.

Original languageEnglish
Pages (from-to)1166-1174
Number of pages9
JournalAnnals of Surgical Oncology
Volume18
Issue number4
DOIs
Publication statusPublished - Apr 1 2011

Fingerprint

Neoplastic Stem Cells
Rectum
Colorectal Neoplasms
Glutaminase
Colon
Neoplasms
Wnt Signaling Pathway
G-Protein-Coupled Receptors
Leucine
Adenoma
Reverse Transcription
Disease-Free Survival
Research Design
Stem Cells
Immunohistochemistry
Gene Expression
Polymerase Chain Reaction
Skin
Survival
Genes

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

Takahashi, H., Ishii, H., Nishida, N., Takemasa, I., Mizushima, T., Ikeda, M., ... Mori, M. (2011). Significance of Lgr5+ve cancer stem cells in the colon and rectum. Annals of Surgical Oncology, 18(4), 1166-1174. https://doi.org/10.1245/s10434-010-1373-9

Significance of Lgr5+ve cancer stem cells in the colon and rectum. / Takahashi, Hidekazu; Ishii, Hideshi; Nishida, Naohiro; Takemasa, Ichiro; Mizushima, Tsunekazu; Ikeda, Masataka; Yokobori, Takehiko; Mimori, Koshi; Yamamoto, Hirofumi; Sekimoto, Mitsugu; Doki, Yuichiro; Mori, Masaki.

In: Annals of Surgical Oncology, Vol. 18, No. 4, 01.04.2011, p. 1166-1174.

Research output: Contribution to journalArticle

Takahashi, H, Ishii, H, Nishida, N, Takemasa, I, Mizushima, T, Ikeda, M, Yokobori, T, Mimori, K, Yamamoto, H, Sekimoto, M, Doki, Y & Mori, M 2011, 'Significance of Lgr5+ve cancer stem cells in the colon and rectum', Annals of Surgical Oncology, vol. 18, no. 4, pp. 1166-1174. https://doi.org/10.1245/s10434-010-1373-9
Takahashi H, Ishii H, Nishida N, Takemasa I, Mizushima T, Ikeda M et al. Significance of Lgr5+ve cancer stem cells in the colon and rectum. Annals of Surgical Oncology. 2011 Apr 1;18(4):1166-1174. https://doi.org/10.1245/s10434-010-1373-9
Takahashi, Hidekazu ; Ishii, Hideshi ; Nishida, Naohiro ; Takemasa, Ichiro ; Mizushima, Tsunekazu ; Ikeda, Masataka ; Yokobori, Takehiko ; Mimori, Koshi ; Yamamoto, Hirofumi ; Sekimoto, Mitsugu ; Doki, Yuichiro ; Mori, Masaki. / Significance of Lgr5+ve cancer stem cells in the colon and rectum. In: Annals of Surgical Oncology. 2011 ; Vol. 18, No. 4. pp. 1166-1174.
@article{df51fa3478334f7ca1721ccc3bfe62f5,
title = "Significance of Lgr5+ve cancer stem cells in the colon and rectum",
abstract = "Purpose: Although recent studies show that leucine-rich repeat-containing G-protein-coupled receptor 5 (Lgr5)+ve cells targeted by Wnt drive self-renewal in the skin and gastrointestinal organs, the clinicopathological significance of Lgr5+ve cancer stem cells (CSCs) of the colon remains to be elucidated. Experimental Design. We studied the Wnt-targeted Lgr5 pathway in colorectal cancer (CRC). The expression of LGR5, c-MYC, p21CIP1/WAF1/CDKN1A, glutaminase (GLS), and miRs-23a and -23b (that target LGR5 and GLS) was evaluated by quantitative real-time reverse-transcription polymerase chain reaction (RT-PCR). The Lgr5 protein was evaluated by immunohistochemistry. The clinical relevance of gene expression in terms of patient survival was also evaluated. Results: Overexpression of LGR5 was significantly associated with expression of c-MYC, p21CIP1/WAF1/ CDKN1A, and GLS (p<0.0001), and inversely associated with miR-23a/b (p<0.05). Immunohistochemical analysis indicated that Lgr5 may be embedded in benign adenomas, localized at the tumor-host interface, and detectable over a broad area in established tumors. High level of LGR5 expression was associated with poor prognosis for CRC cancer patients (disease-free survival; p<0.05). Conclusions: This study supports a significant role for LGR5 in the CSC hypothesis in CRC: (1) Lgr5+ve CSCs, presumably derived from normal stem cells in colonic crypts, proliferate, and the gene is overexpressed during CRC development; (2) LGR5 expression is associated with activation of Wnt pathway, including oncogenic c-MYC and high energy production via glutaminolysis; (3) LGR5 expression may be a poor prognostic factor for CRC patients. Further study of LGR5 should contribute to the development of CSC-based cancer therapeutics.",
author = "Hidekazu Takahashi and Hideshi Ishii and Naohiro Nishida and Ichiro Takemasa and Tsunekazu Mizushima and Masataka Ikeda and Takehiko Yokobori and Koshi Mimori and Hirofumi Yamamoto and Mitsugu Sekimoto and Yuichiro Doki and Masaki Mori",
year = "2011",
month = "4",
day = "1",
doi = "10.1245/s10434-010-1373-9",
language = "English",
volume = "18",
pages = "1166--1174",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Significance of Lgr5+ve cancer stem cells in the colon and rectum

AU - Takahashi, Hidekazu

AU - Ishii, Hideshi

AU - Nishida, Naohiro

AU - Takemasa, Ichiro

AU - Mizushima, Tsunekazu

AU - Ikeda, Masataka

AU - Yokobori, Takehiko

AU - Mimori, Koshi

AU - Yamamoto, Hirofumi

AU - Sekimoto, Mitsugu

AU - Doki, Yuichiro

AU - Mori, Masaki

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Purpose: Although recent studies show that leucine-rich repeat-containing G-protein-coupled receptor 5 (Lgr5)+ve cells targeted by Wnt drive self-renewal in the skin and gastrointestinal organs, the clinicopathological significance of Lgr5+ve cancer stem cells (CSCs) of the colon remains to be elucidated. Experimental Design. We studied the Wnt-targeted Lgr5 pathway in colorectal cancer (CRC). The expression of LGR5, c-MYC, p21CIP1/WAF1/CDKN1A, glutaminase (GLS), and miRs-23a and -23b (that target LGR5 and GLS) was evaluated by quantitative real-time reverse-transcription polymerase chain reaction (RT-PCR). The Lgr5 protein was evaluated by immunohistochemistry. The clinical relevance of gene expression in terms of patient survival was also evaluated. Results: Overexpression of LGR5 was significantly associated with expression of c-MYC, p21CIP1/WAF1/ CDKN1A, and GLS (p<0.0001), and inversely associated with miR-23a/b (p<0.05). Immunohistochemical analysis indicated that Lgr5 may be embedded in benign adenomas, localized at the tumor-host interface, and detectable over a broad area in established tumors. High level of LGR5 expression was associated with poor prognosis for CRC cancer patients (disease-free survival; p<0.05). Conclusions: This study supports a significant role for LGR5 in the CSC hypothesis in CRC: (1) Lgr5+ve CSCs, presumably derived from normal stem cells in colonic crypts, proliferate, and the gene is overexpressed during CRC development; (2) LGR5 expression is associated with activation of Wnt pathway, including oncogenic c-MYC and high energy production via glutaminolysis; (3) LGR5 expression may be a poor prognostic factor for CRC patients. Further study of LGR5 should contribute to the development of CSC-based cancer therapeutics.

AB - Purpose: Although recent studies show that leucine-rich repeat-containing G-protein-coupled receptor 5 (Lgr5)+ve cells targeted by Wnt drive self-renewal in the skin and gastrointestinal organs, the clinicopathological significance of Lgr5+ve cancer stem cells (CSCs) of the colon remains to be elucidated. Experimental Design. We studied the Wnt-targeted Lgr5 pathway in colorectal cancer (CRC). The expression of LGR5, c-MYC, p21CIP1/WAF1/CDKN1A, glutaminase (GLS), and miRs-23a and -23b (that target LGR5 and GLS) was evaluated by quantitative real-time reverse-transcription polymerase chain reaction (RT-PCR). The Lgr5 protein was evaluated by immunohistochemistry. The clinical relevance of gene expression in terms of patient survival was also evaluated. Results: Overexpression of LGR5 was significantly associated with expression of c-MYC, p21CIP1/WAF1/ CDKN1A, and GLS (p<0.0001), and inversely associated with miR-23a/b (p<0.05). Immunohistochemical analysis indicated that Lgr5 may be embedded in benign adenomas, localized at the tumor-host interface, and detectable over a broad area in established tumors. High level of LGR5 expression was associated with poor prognosis for CRC cancer patients (disease-free survival; p<0.05). Conclusions: This study supports a significant role for LGR5 in the CSC hypothesis in CRC: (1) Lgr5+ve CSCs, presumably derived from normal stem cells in colonic crypts, proliferate, and the gene is overexpressed during CRC development; (2) LGR5 expression is associated with activation of Wnt pathway, including oncogenic c-MYC and high energy production via glutaminolysis; (3) LGR5 expression may be a poor prognostic factor for CRC patients. Further study of LGR5 should contribute to the development of CSC-based cancer therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=79955800644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955800644&partnerID=8YFLogxK

U2 - 10.1245/s10434-010-1373-9

DO - 10.1245/s10434-010-1373-9

M3 - Article

C2 - 21125339

AN - SCOPUS:79955800644

VL - 18

SP - 1166

EP - 1174

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 4

ER -